Insight Search Search Submit Sort by: Relevance Date Search Sort by RelevanceDate Order AscDesc Podcast March 22, 2023 Podcast | Post-Quantum Cryptography Today— with Skip Norton from Quintessence Labs Is your organization post-quantum ready? NIST’s finalists for PQC ciphers are expected in 2024, and time is running out to prepare for their implementation. Regulators will force this migration long before quantum computing hardware actually cracks encryption. The path to being ready for post-quantum cryptography will require assessing your organization’s crypto agility, and will certainly… Survey March 27, 2023 Industry Experience With Remote Branch Inspections Beginning in 2020, the Financial Industry Regulatory Authority (FINRA), the Securities and Exchange Commission (SEC) and several states provided temporary relief from the operational challenges of conducting on-site branch inspections during the pandemic, allowing firms to utilize technology to fulfill their inspection obligations remotely. Now, FINRA has proposed a voluntary, three-year remote… Survey November 13, 2019 An Urgent Call for KYC Optimization - A Global Market Study Calling for KYC Innovation and Collaboration Protiviti and the International RegTech Association (IRTA) conducted a global study to investigate the effectiveness of existing (AML) know your customer (KYC or AML/KYC) processes, their impact on customer experience across various jurisdictions and the efforts by financial institutions to innovate KYC controls. This study focuses on the optimization of KYC processes. It provides a blueprint for… Podcast Transcript March 28, 2023 Transcript | Future of Crypto Innovation and Regulation Over the past year, as one crypto organization after another has been beset by fraud or declared bankruptcy, countless headlines have surfaced warning of the death of the crypto industry. Yet the damage has been largely contained. The developments have raised many questions about digital assets, cryptocurrency and blockchain technology as well as regulation and other factors that may help the… Whitepaper April 27, 2023 Price Transparency Compliance Price transparency compliance continues to elude hospitals two years after its effective date on January 1, 2021. While the Hospital Price Transparency (HPT) rule was met with great debate within the industry, the Centers for Medicare and Medicaid Services (CMS) continues its initiatives for ensuring greater transparency in healthcare. An audit of price transparency can prompt further compliance… Whitepaper April 4, 2023 Tech CFOs Discuss Banking Market Disruption and People Problems Chief financial officers (CFOs) in the technology sector met to discuss leading industry practices, trends and other topics of mutual interest in a virtual roundtable conducted under the Chatham House Rule. The agenda for this virtual exchange, hosted by Protiviti Managing Directors Gordon Tucker, Christopher Wright and Fran Maxwell, was created through a series of pre-interviews. Comments from… Podcast January 10, 2023 Commentary by Sharon Lindstrom | 2023 Top Risks Survey — Manufacturing and Distribution Sharon Lindstrom, Managing Director and Global Leader of Protiviti’s Manufacturing and Distribution industry group, comments on short- and long-term trends in the market based on research from Protiviti's 2023 Top Risks Survey. Podcast January 10, 2023 Commentary by Nick McKeehan | 2023 Top Risks Survey — Distribution and Logistics Managing Director Nick McKeehan comments on the market landscape for distribution and logistics organizations based on research from Protiviti's 2023 Top Risks Survey. Podcast January 10, 2023 Commentary by Sean Humphreys | 2023 Top Risks Survey — Materials and Chemicals Managing Director Sean Humphreys describes current and future market challenges for organizations in the materials and chemicals industry based on research from Protiviti's 2023 Top Risks Survey. Podcast January 10, 2023 Commentary by Keith Kawashima | 2023 Top Risks Survey — Pharmaceuticals and Life Sciences Managing Director Keith Kawashima provides an overview of the risk landscape for pharmaceuticals and life sciences organizations based on research from Protiviti's 2023 Top Risks Survey. Load More
